Eskayef Pharmaceuticals Ltd
Eskayef Pharmaceuticals Ltd., commonly referred to as Eskayef, is a leading pharmaceutical company headquartered in Dhaka, Bangladesh (BD). Established in 1990, Eskayef has made significant strides in the industry, focusing on the development, manufacturing, and marketing of a diverse range of pharmaceutical products. The company operates primarily in the generic and branded medicine sectors, offering a portfolio that includes antibiotics, anti-inflammatory drugs, and cardiovascular medications. Eskayef is renowned for its commitment to quality and innovation, which has positioned it as a trusted name in the pharmaceutical landscape. With a strong market presence in Bangladesh and expanding operations in international markets, Eskayef Pharmaceuticals has achieved notable milestones, including various certifications and awards that underscore its dedication to excellence in healthcare.
DitchCarbon Score
How does Eskayef Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eskayef Pharmaceuticals Ltd's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eskayef Pharmaceuticals Ltd's reported carbon emissions
Eskayef Pharmaceuticals Ltd, headquartered in Bangladesh (BD), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that Eskayef Pharmaceuticals has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability and carbon footprint reduction, Eskayef Pharmaceuticals may benefit from establishing clear climate commitments and measurable targets to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eskayef Pharmaceuticals Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
